JP2002524491A5 - - Google Patents

Download PDF

Info

Publication number
JP2002524491A5
JP2002524491A5 JP2000569778A JP2000569778A JP2002524491A5 JP 2002524491 A5 JP2002524491 A5 JP 2002524491A5 JP 2000569778 A JP2000569778 A JP 2000569778A JP 2000569778 A JP2000569778 A JP 2000569778A JP 2002524491 A5 JP2002524491 A5 JP 2002524491A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000569778A
Other languages
Japanese (ja)
Other versions
JP2002524491A (ja
Filing date
Publication date
Priority claimed from US09/153,133 external-priority patent/US8333996B2/en
Application filed filed Critical
Publication of JP2002524491A publication Critical patent/JP2002524491A/ja
Publication of JP2002524491A5 publication Critical patent/JP2002524491A5/ja
Pending legal-status Critical Current

Links

JP2000569778A 1998-09-15 1999-09-14 燐酸カルシウム送出ビヒクル及びアジュバント Pending JP2002524491A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/153,133 1998-09-15
US09/153,133 US8333996B2 (en) 1995-05-19 1998-09-15 Calcium phosphate delivery vehicle and adjuvant
PCT/US1999/021182 WO2000015194A1 (en) 1998-09-15 1999-09-14 Calcium phosphate delivery vehicle and adjuvant

Publications (2)

Publication Number Publication Date
JP2002524491A JP2002524491A (ja) 2002-08-06
JP2002524491A5 true JP2002524491A5 (cg-RX-API-DMAC7.html) 2005-12-08

Family

ID=22545915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000569778A Pending JP2002524491A (ja) 1998-09-15 1999-09-14 燐酸カルシウム送出ビヒクル及びアジュバント

Country Status (8)

Country Link
US (1) US8333996B2 (cg-RX-API-DMAC7.html)
EP (1) EP1117381A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002524491A (cg-RX-API-DMAC7.html)
KR (2) KR20060113798A (cg-RX-API-DMAC7.html)
AU (1) AU763487B2 (cg-RX-API-DMAC7.html)
CA (1) CA2342207A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ510198A (cg-RX-API-DMAC7.html)
WO (1) WO2000015194A1 (cg-RX-API-DMAC7.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US6355271B1 (en) * 1999-02-03 2002-03-12 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
EP1471034A3 (en) * 1999-02-03 2005-03-02 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
ATE303169T1 (de) 2001-11-19 2005-09-15 Scil Technology Gmbh Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften
CN100522241C (zh) * 2002-09-10 2009-08-05 Scil技术股份有限公司 在低氧气浓度下用骨诱导蛋白包被的金属植入物
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
EP1599170B1 (en) * 2003-02-21 2013-01-16 Hasumi Llc (Dba Shukokai International) Human lymphocyte vaccine adjuvant
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
GB0307011D0 (en) * 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
EP1615596B1 (en) 2003-04-11 2016-11-02 Etex Corporation Osteoinductive bone material
WO2004098457A1 (en) * 2003-04-30 2004-11-18 Therics, Inc. Bone void filler and method of manufacture
FR2856672A1 (fr) * 2003-06-30 2004-12-31 Rhodia Chimie Sa Plaquettes de phosphate de calcium nanometrique.
FR2857268B1 (fr) * 2003-07-08 2007-09-21 Urodelia Composite injectable pour magnetocytolyse de cellules metastatiques osseuses
TW200518767A (en) * 2003-09-12 2005-06-16 Wyeth Corp Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
PL1680089T3 (pl) 2003-10-22 2014-03-31 Lidds Ab Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków
EP1720520B1 (en) 2004-02-13 2010-06-09 Nod Pharmaceuticals, Inc. Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
US8586090B2 (en) * 2004-10-05 2013-11-19 Albert Einstein College Of Medicine Of Yeshiva University Melanin nanoshells for protection against radiation and electronic pulses
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
AU2005306857A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
CN101098673B (zh) * 2004-11-16 2012-02-29 3M创新有限公司 包括磷酸盐的牙科填料和组合物
AU2005306869B2 (en) * 2004-11-16 2011-11-10 3M Innovative Properties Company Dental fillers including a phosphorus­containing surface treatment
CA2587278A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
FR2885525B1 (fr) * 2005-05-13 2009-09-18 Urodelia Sa Medicament notamment anti-cancereux, destine a des traitements par immunotherapie, en particulier autologue
CA2629600C (en) * 2005-11-14 2011-11-01 Biomet 3I, Inc. Deposition of discrete nanoparticles on an implant surface
EP1970074A4 (en) * 2006-01-06 2009-03-04 Cell Medicine Inc IMMUNE ADJUVANT
EP1987769B1 (en) * 2006-02-23 2019-04-10 University Corporation, Kanazawa Institute of Technology Superconducting magnetism measuring device
AU2007224651B8 (en) 2006-03-14 2011-10-27 Lidds Ab Bioresorbable controlled-release composition
US8017237B2 (en) * 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
ES2729425T3 (es) 2006-10-24 2019-11-04 Biomet 3I Llc Deposición de nanopartículas discretas sobre una superficie nanoestructurada de un implante
EP2229130A2 (en) * 2007-12-13 2010-09-22 3M Innovative Properties Company Remineralizing compositions and methods
JP5806466B2 (ja) 2008-01-28 2015-11-10 バイオメット・3アイ・エルエルシー 親水性を向上させたインプラント表面
EP2358651A2 (en) 2008-11-12 2011-08-24 Engqvist, Håkan Hydraulic cements, methods and products
JP2009084292A (ja) * 2008-11-14 2009-04-23 Cell-Medicine Inc 免疫アジュバント
JP5274214B2 (ja) * 2008-11-25 2013-08-28 オリンパス株式会社 癌細胞抑制シート
WO2010068359A1 (en) * 2008-12-11 2010-06-17 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
JP5633152B2 (ja) * 2010-02-16 2014-12-03 東ソー株式会社 アジュバント
JP5871822B2 (ja) 2010-03-10 2016-03-01 オスディーサイン アーベー 組織欠損を補正するためのインプラントおよび方法
US8641418B2 (en) * 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
PH12013501524A1 (en) 2011-01-19 2022-10-26 Laboratory Skin Care Inc Topical minocycline compositions and methods of using the same
WO2012105219A1 (ja) * 2011-01-31 2012-08-09 オリンパス株式会社 抗体療法の効果増強剤
JP6082901B2 (ja) * 2011-01-31 2017-02-22 オリンパス株式会社 ワクチン・アジュバント
JP5966129B2 (ja) * 2011-01-31 2016-08-10 オリンパス株式会社 免疫賦活剤
US9463046B2 (en) 2011-08-22 2016-10-11 Ossdsign Ab Implants and methods for using such implants to fill holes in bone tissue
US8591645B2 (en) 2011-09-09 2013-11-26 Ossdsign Ab Hydraulic cements with optimized grain size distribution, methods, articles and kits
US20130066327A1 (en) 2011-09-09 2013-03-14 Håkan Engqvist Hydraulic cement compositions with low ph methods, articles and kits
JP5999639B2 (ja) * 2011-11-25 2016-09-28 国立研究開発法人産業技術総合研究所 免疫刺激因子担持微粒子
EP2796141A1 (en) * 2011-12-22 2014-10-29 Olympus Corporation Cancer cell-inhibiting ceramics and method for producing cancer cell-inhibiting ceramics, method for treating bone neoplasm, and use of b tricalcium phosphate porous granules having grain size of 1 to 10 mm
ES2671740T3 (es) 2012-03-20 2018-06-08 Biomet 3I, Llc Superficie de tratamiento para una superficie de implante
EP2931325B1 (en) 2012-12-14 2020-02-19 OssDsign AB Cement-forming compositions, monetite cements, implants and methods for correcting bone defects
HK1217632A1 (zh) 2013-02-12 2017-01-20 Ossdsign Ab 镶嵌型植人物、试剂盒和用於矫正骨缺损的方法
EP2988777B1 (en) * 2013-04-24 2021-02-17 Medizinische Universität Wien Novel vaccine formulation for ocular immunization
GB201318858D0 (en) * 2013-10-25 2013-12-11 Glaxosmithkline Biolog Sa Calcium fluoride compositions
GB201318862D0 (en) * 2013-10-25 2013-12-11 Glaxosmithkline Biolog Sa Calcium fluoride compositions
KR20170043110A (ko) 2014-08-14 2017-04-20 오에스에스디자인 아베 뼈 결함 교정을 위한 뼈 이식
US20180353598A1 (en) * 2015-09-17 2018-12-13 National Institutes Of Biomedical Innovation, Health And Nutrition Optimization of physiological properties of calcium phosphate as vaccine adjuvant
CN112969422B (zh) 2018-10-16 2024-07-12 奥斯设计公司 用于填充骨中钻孔的植入物和用于填充骨中钻孔的方法
WO2020158833A1 (ja) 2019-01-31 2020-08-06 セルメディシン株式会社 無機塩類タンパク複合医療機器
CU20200032A7 (es) * 2020-06-09 2022-01-13 Ct Inmunologia Molecular Composiciones vacunales basadas en nano-partículas de fosfatos de calcio para el tratamiento del cáncer
WO2025196846A1 (en) * 2024-03-21 2025-09-25 Amrita Vishwa Vidyapeetham Immunotherapeutic composition and preparation thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2967802A (en) 1957-12-02 1961-01-10 Diamond Lab Hydrated calcium phosphate gelantigen composition and method of preparing same
FR1604134A (cg-RX-API-DMAC7.html) 1967-09-26 1971-07-12
US4016252A (en) 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
FR2181426B1 (cg-RX-API-DMAC7.html) 1972-04-06 1974-12-20 Pasteur Institut
SE7506313L (sv) * 1974-06-04 1975-12-05 Wellcome Found Sett att framstella ett prostaglandinkonjugat
EP0007895B1 (fr) 1978-07-19 1983-06-22 Patrick Couvreur Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation
US5085861A (en) * 1987-03-12 1992-02-04 The Beth Israel Hospital Association Bioerodable implant composition comprising crosslinked biodegradable polyesters
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5290558A (en) * 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
US5462751A (en) * 1990-06-22 1995-10-31 The Regeants Of The University Of California Biological and pharmaceutical agents having a nanomeric biodegradable core
US5782971B1 (en) * 1991-06-28 1999-09-21 Norian Corp Calcium phosphate cements comprising amorophous calcium phosphate
US5728385A (en) * 1993-08-12 1998-03-17 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
US5508342A (en) * 1994-02-01 1996-04-16 The United States Of America As Represented By The Secretary Of Commerce Polymeric amorphous calcium phosphate compositions
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6117456A (en) 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6541037B1 (en) * 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
CA2268156C (en) 1996-10-16 2007-05-29 Etex Corporation Bioceramic compositions
US5968253A (en) * 1998-07-31 1999-10-19 Norian Corporation Calcium phosphate cements comprising antimicrobial agents

Similar Documents

Publication Publication Date Title
BE2018C020I2 (cg-RX-API-DMAC7.html)
BE2015C057I2 (cg-RX-API-DMAC7.html)
BE2016C007I2 (cg-RX-API-DMAC7.html)
BE2014C017I2 (cg-RX-API-DMAC7.html)
BE2013C051I2 (cg-RX-API-DMAC7.html)
BE2013C020I2 (cg-RX-API-DMAC7.html)
BE2013C015I2 (cg-RX-API-DMAC7.html)
BE2013C001I2 (cg-RX-API-DMAC7.html)
BE2012C036I2 (cg-RX-API-DMAC7.html)
BE2008C046I2 (cg-RX-API-DMAC7.html)
BE1025464I2 (cg-RX-API-DMAC7.html)
BE2010C011I2 (cg-RX-API-DMAC7.html)
BE2008C047I2 (cg-RX-API-DMAC7.html)
BE2011C004I2 (cg-RX-API-DMAC7.html)
JP2002518717A5 (cg-RX-API-DMAC7.html)
BRPI0001672A2 (cg-RX-API-DMAC7.html)
BRPI0001542A2 (cg-RX-API-DMAC7.html)
JP2002524907A5 (cg-RX-API-DMAC7.html)
JP2002525811A5 (cg-RX-API-DMAC7.html)
BRPI0012675B8 (cg-RX-API-DMAC7.html)
BRPI0017522A2 (cg-RX-API-DMAC7.html)
JP2002528346A5 (cg-RX-API-DMAC7.html)
JP2002522707A5 (cg-RX-API-DMAC7.html)
BRPI0303609A (cg-RX-API-DMAC7.html)
BRPI9917761A2 (cg-RX-API-DMAC7.html)